Concentric Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.69M | Sell |
29,920
-1,127
| -4% | -$94.8K | 0.66% | 57 |
|
|
2024
Q2 | $2.44M | Buy |
31,047
+1,105
| +4% | +$90.6K | 0.64% | 56 |
|
|
2024
Q1 | $2.61M | Buy |
29,942
+1,249
| +4% | +$107K | 0.69% | 55 |
|
|
2023
Q4 | $2.36M | Buy |
28,693
+2,280
| +9% | +$174K | 0.69% | 57 |
|
|
2023
Q3 | $2.07M | Buy |
26,413
+115
| +0.4% | +$9.6K | 0.68% | 57 |
|
|
2023
Q2 | $2.32M | Buy |
26,298
+228
| +0.9% | +$19.6K | 0.74% | 56 |
|
|
2023
Q1 | $2.1M | Buy |
26,070
+750
| +3% | +$61.1K | 0.7% | 56 |
|
|
2022
Q4 | $1.97M | Sell |
25,320
-812
| -3% | -$65.8K | 0.67% | 58 |
|
|
2022
Q3 | $2.11M | Buy |
26,132
+585
| +2% | +$52.6K | 0.78% | 52 |
|
|
2022
Q2 | $2.29M | Buy |
25,547
+1,580
| +7% | +$160K | 0.77% | 53 |
|
|
2022
Q1 | $2.66M | Buy |
23,967
+227
| +1% | +$24K | 0.77% | 53 |
|
|
2021
Q4 | $2.46M | Buy |
23,740
+1,032
| +5% | +$120K | 0.69% | 55 |
|
|
2021
Q3 | $2.85M | Sell |
22,708
-44
| -0.2% | -$5.7K | 0.87% | 49 |
|
|
2021
Q2 | $2.82M | Buy |
22,752
+55
| +0.2% | +$6.91K | 0.86% | 48 |
|
|
2021
Q1 | $2.68M | Buy |
22,697
+1,010
| +5% | +$118K | 0.88% | 45 |
|
|
2020
Q4 | $2.54M | Buy |
21,687
+216
| +1% | +$23.8K | 0.93% | 43 |
|
|
2020
Q3 | $2.23M | Buy |
21,471
+140
| +0.7% | +$14.1K | 0.96% | 41 |
|
|
2020
Q2 | $1.96M | Buy |
21,331
+2,025
| +10% | +$194K | 0.92% | 42 |
|
|
2020
Q1 | $1.74M | Buy |
19,306
+40
| +0.2% | +$4.26K | 0.96% | 42 |
|
|
2019
Q4 | $2.19M | Sell |
19,266
-215
| -1% | -$23.6K | 0.94% | 43 |
|
|
2019
Q3 | $2.12M | Sell |
19,481
-55
| -0.3% | -$5.74K | 1.35% | 32 |
|
|
2019
Q2 | $1.9M | Buy |
19,536
+595
| +3% | +$54.3K | 1.24% | 36 |
|
|
2019
Q1 | $1.72M | Buy |
18,941
+240
| +1% | +$21.5K | 1.17% | 39 |
|
|
2018
Q4 | $1.7M | Sell |
18,701
-47
| -0.3% | -$4.39K | 1.31% | 33 |
|
|
2018
Q3 | $1.84M | Sell |
18,748
-145
| -0.8% | -$13.4K | 1.29% | 33 |
|
|
2018
Q2 | $1.62M | Sell |
18,893
-125
| -0.7% | -$10.4K | 1.16% | 36 |
|
|
2018
Q1 | $1.53M | Buy |
19,018
+170
| +0.9% | +$14K | 1.13% | 38 |
|
|
2017
Q4 | $1.52M | Buy |
18,848
+468
| +3% | +$37.5K | 1.1% | 40 |
|
|
2017
Q3 | $1.43M | Buy |
18,380
+145
| +0.8% | +$12K | 1.08% | 42 |
|
|
2017
Q2 | $1.62M | Sell |
18,235
-365
| -2% | -$30.8K | 1.28% | 33 |
|
|
2017
Q1 | $1.5M | Buy |
18,600
+23
| +0.1% | +$1.8K | 1.22% | 38 |
|
|
2016
Q4 | $1.32M | Buy |
+18,577
| New | +$1.46M | 1.11% | 40 |
|
Other funds holding MDT
Concentric Wealth Management's MDT Position: Q3 2024 in Review
Concentric Wealth Management reduced its Medtronic (MDT) stake by 3.6% in Q3 2024, selling an estimated $94.8K and leaving 29,920 shares worth $2.69M. The position accounts for 0.66% of the portfolio, ranked #57.
Concentric Wealth Management first reported a position in MDT in Q4 2016 and has held it in 32 quarters since. The position peaked at $2.85M in Q3 2021. 2,070 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Concentric Wealth Management held 29,920 shares of Medtronic worth $2.69M as of Q3 2024.
- Concentric Wealth Management sold 1,127 Medtronic shares in Q3 2024, an estimated $94.8K.
- Medtronic made up 0.66% of Concentric Wealth Management's portfolio in Q3 2024, its #57 holding.
- Concentric Wealth Management first reported a position in Medtronic in Q4 2016 and has held it in 32 quarters since.
- Concentric Wealth Management's Medtronic position peaked at $2.85M in Q3 2021.
- 2,070 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.